Because of the lack of adult patients with mild to moderate cases of COVID-19 for the clinical trials, a new report revealed that a team of experts in China suspended their research for the drug remdesivir, which is a potential COVID-19 treatment.Original Article
Experimental Coronavirus Treatment Trial Suspended By Chinese Researchers Due To Insufficient Patients
